Tau-Cardia
Breakthrough Technology for the Management of Heart Failure
Company Overview
Snapshot
Founded in September 2022 by Amit Ashkenazi and Reuven Lewinsky, Tau-Cardia operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing breakthrough technology for heart failure management.
Business overview
Tau-Cardia is a Health Tech & Life Sciences company developing breakthrough technology for the management of heart failure. Operating within the Medical Devices and Medical Treatment & Therapeutics sectors, the company's core focus is on creating innovative solutions to address critical needs in cardiology. Tau-Cardia serves the healthcare and life sciences industries, specifically targeting the medical devices industry and healthcare providers with its medical equipment.
Company Intelligence Q&A
- When was Tau-Cardia founded?
- Tau-Cardia was founded in September 2022.
- Who are the founders of Tau-Cardia?
- The co-founders of Tau-Cardia are Amit Ashkenazi, who serves as CEO, and Reuven Lewinsky, who is the CSO.
- What is Tau-Cardia's primary focus?
- Tau-Cardia is focused on developing breakthrough technology for the management of heart failure.
- In which sector does Tau-Cardia primarily operate?
- Tau-Cardia's primary sector is Health Tech & Life Sciences, with a specific focus on Medical Devices and Medical Treatment & Therapeutics.
- What is the current product development stage for Tau-Cardia?
- Tau-Cardia's product is currently in the Research and Development (R&D) stage, focusing on developing its breakthrough technology for heart failure management.